Iceland· IS-EU/1/22/1671/002
Sunlenca
A lenacapavir product containing lenacapavirum inn, registered in Iceland by Gilead Sciences Ireland UC*. The same ATC class is registered in 15 of our 19 countries.
Checked against Icelandic Medicines Agency (Iceland) on
Informational only — not a medical device.
Where it is registered
Lenacapavir is registered in 15 of 19 countries.
Countries holding a registration under ATC J05AX31 (lenacapavir), each read from that country’s own register.
- This record: Iceland, from Icelandic Medicines Agency (Iceland)
- 10 of them publish a price we can compare per daily dose
Lenacapavir · ATC J05AX31
15 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Icelandprice
- Ireland
- Netherlands
- Norwayprice
- Polandprice
- Spainprice
- Switzerlandprice
- United Kingdom
- United Statesprice
Price per daily dose
What a daily dose of lenacapavir costs, country by country.
Normalised to the WHO defined daily dose (0.19 g), the median price runs from $0.45 in France to $511.10 in Switzerland — a ×1140 gap.
- 2 markets with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Lenacapavir · price per daily dose (0.19 g)
USD · FX 28 Sept 2026
- CH Switzerland$511.10
- FR France$0.45
The record
At a glance
Icelandic Medicines Agency (Iceland)- Active substance
- Lenacapavirum INN
- Manufacturer
- Gilead Sciences Ireland UC*
- Country
- Iceland (IS)
- ATC code
- J05AX31
- ATC class
- Lenacapavir
- Defined daily dose
- 0.19 g, O
- Reimbursed
- Not published by this register
- Source register
- Icelandic Medicines Agency (Iceland)
- Last checked
- September 29, 2026
Packs & prices · 1
1 priced- ean9974711,5 ml x2 hglISK 3872560
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Lenacapavir in 14 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CzechiaSUNLENCAGilead Sciences Ireland UC, Carrigtohill
- PolandSunlencaGilead Sciences Ireland UC
- SwedenSunlenca 464 mg Injektionsvätska, lösningGilead Sciences Ireland UC
- BelgiumSunlenca 464 mgGilead Sciences Ireland UC
- SpainSUNLENCA 464 MG SOLUCION INYECTABLEGilead Sciences Ireland Unlimited Company
- NorwaySunlencaGilead Sciences Ireland UC
- United StatesSunlencaGilead Sciences, Inc.
- FinlandSunlencaGilead Sciences Ireland UC
Authorised across Europe · EMA
The same active substance is authorised in 2 EEA countries. Names it is sold under:
- Liechtenstein · Sunlenca, Yeytuo
- Norway · Sunlenca, Yeytuo
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Icelandic Medicines Agency (Iceland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/75a04893-b81a-4a0b-9d02-08ad486a9de8 GET /v1/drugs/75a04893-b81a-4a0b-9d02-08ad486a9de8?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Stungulyf, lausn",
"source": "lyfjastofnun",
"atc_raw": "J05AX31",
"marketed": false,
"strength": "464 mg",
"ma_number": "EU/1/22/1671/002",
"substance": "Lenacapavirum INN",
"other_info": null,
"legal_status": "(R) Lyfseðilsskylt\r\n(H) Sjúkrahúsmerkt",
"ma_issued_serial": "44790"
}See everything about lenacapavir.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.